carcinoembryon
antigenrel
cell
adhes
molecul
transmembran
glycoprotein
express
epitheli
endotheli
immun
cell
differenti
antigen
involv
mainten
epitheli
polar
induc
hepatocyt
differenti
liver
regener
regul
insulin
sensit
promot
hepat
insulin
clearanc
control
liver
toler
mucos
immun
obes
insulinresist
human
nonalcohol
fatti
liver
diseas
manifest
loss
hepat
mice
delet
function
inactiv
impair
insulin
clearanc
compromis
metabol
homeostasi
initi
develop
obes
hepat
steatosi
fibrosi
featur
nonalcohol
steatohepat
adipogenesi
white
adipos
depot
follow
inflamm
endotheli
cardiovascular
dysfunct
obstruct
inflammatori
liver
diseas
solubl
shed
human
bile
serv
indic
liver
diseas
immun
cell
act
immun
checkpoint
regul
delet
gene
mice
caus
exacerb
inflamm
hyperactiv
myeloid
cell
lymphocyt
henc
hepat
resid
central
hub
immun
metabol
homeostasi
human
mice
review
focus
regulatori
role
liver
biliari
tract
architectur
health
diseas
metabol
role
function
immun
checkpoint
regul
hepat
inflamm
carcinoembryon
antigenrel
cell
adhes
molecul
member
cea
famili
highli
glycosyl
cellular
adhes
molecul
belong
immunoglobulin
superfamili
cea
protein
built
highli
conserv
modular
set
ntermin
variablelik
constantlik
immunoglobulin
domain
mediat
ci
tran
homophil
heterophil
adhes
amongst
member
cea
famili
human
gene
undergo
extens
altern
splice
give
rise
splice
variant
two
major
isoform
human
mice
contain
four
extracellular
domain
either
long
short
cytoplasm
tail
respect
differenti
control
cellular
activ
differenti
migrationinvas
prolifer
commonli
express
pair
splice
variant
gene
contain
two
extracellular
domain
either
long
short
cytoplasm
tail
respect
ceacam
famili
uniqu
cytoplasm
tail
contain
two
immunoreceptor
tyrosin
receptorbas
inhibit
motif
itim
consensu
sequenc
sivlxyxxivl
human
two
immunoreceptor
tyrosinebas
switch
motif
itsm
consensu
sequenc
txyxx
vi
rodent
structur
featur
indic
transmit
inhibitori
signal
upon
ligand
coreceptor
engag
contain
two
tyrosin
residu
substrat
srckinas
dephosphoryl
inhibitori
tyrosin
phosphatas
short
isoform
bind
calmodulin
tropomyosin
globular
actin
annexin
ii
polymeras
delta
interact
protein
phosphoryl
protein
kinas
regul
cytoskelet
dynam
differ
frequent
coexpress
cell
rel
express
level
determin
outcom
cellular
signal
discoveri
character
call
best
summar
converg
parallel
evolutionari
thread
describ
differ
biolog
context
nonspecif
crossreact
antigen
antibodi
direct
cea
biliari
glycoproteini
bgpi
calciumdepend
cellcel
adhes
molecul
rat
hepatocellular
membran
ectoatpas
hepatocellular
membran
transformationsensit
glycoprotein
substrat
insulin
receptor
murin
hepat
viru
receptor
cea
gene
famili
member
mous
protein
cluster
differenti
cd
antigen
human
neutrophil
heterogen
nomenclatur
revis
defin
individu
ceacam
unanim
member
cea
famili
cell
adhes
molecul
assign
individu
ceacam
number
figur
express
epithelia
endothelia
leukocyt
absent
skelet
muscl
myocyt
cartilag
protein
structur
function
conserv
human
rodent
share
tissu
express
pattern
mice
four
major
isoform
exist
compris
isoform
well
two
isoform
two
extracellular
domain
either
long
short
cytoplasm
tail
wwwceahomepaged
addit
strainspecif
allel
variant
sjlj
mice
discov
wherea
balbc
mice
express
common
allel
human
differ
ceacam
gene
encod
function
protein
cea
amongst
express
solubl
protein
well
possess
transmembran
anchor
cytoplasm
tail
repres
l
wherea
gpilink
b
schemat
represent
protein
isoform
product
altern
splice
human
gene
promin
beststudi
isoform
highlight
blue
box
either
compris
long
l
short
cytoplasm
tail
four
three
extracellular
immunoglobulinlik
domain
respect
amongst
isoform
variant
found
modifi
short
cytoplasm
tail
solubl
isoform
addit
solubl
isoform
includ
membranebound
well
compris
one
extracellular
domain
function
remain
elus
detail
hyperlink
protein
databas
found
wwwcarcinoembryonicantigend
full
list
gene
encod
ceacam
protein
human
rodent
found
adapt
modifi
form
wwwcarcinoembryonicantigend
permiss
carcinoembryon
antigen
origin
detect
search
tumorspecif
antigen
colon
later
normal
tissu
antigen
fetal
adult
digest
tract
first
describ
biliari
glycoprotein
bgp
cealik
substanc
human
hepat
bile
svenberg
et
al
discov
compon
human
bile
patient
promin
beststudi
isoform
highlight
blue
box
either
compris
long
l
short
cytoplasm
tail
four
three
extracellular
immunoglobulinlik
domain
respect
amongst
isoform
variant
found
modifi
short
cytoplasm
tail
solubl
isoform
addit
solubl
isoform
includ
membranebound
well
compris
one
extracellular
domain
function
remain
elus
detail
hyperlink
protein
databas
found
wwwcarcinoembryonicantigend
full
list
gene
encod
ceacam
protein
human
rodent
found
adapt
modifi
form
wwwcarcinoembryonicantigend
permiss
carcinoembryon
antigen
origin
detect
search
tumorspecif
antigen
colon
later
normal
tissu
antigen
fetal
adult
digest
tract
first
describ
biliari
glycoprotein
bgp
cealik
substanc
human
hepat
bile
svenberg
et
al
discov
compon
human
bile
patient
biliari
obstruct
exhibit
crossreact
anticea
antisera
absenc
gastrointestin
malign
purif
partial
character
biliari
glycoprotein
bgpi
hepat
bile
enabl
first
partial
character
later
renam
specif
associ
bgpisolubl
express
serum
patient
obstruct
liver
diseas
found
inde
bgpi
serum
level
consid
surrog
marker
variou
liver
diseas
chronic
hepat
alcohol
cirrhosi
primari
biliari
cirrhosi
compar
valid
establish
marker
gamma
glutaryl
transferas
ggt
alkalin
phosphatas
alp
instanc
serum
bgpi
fiveto
tenfold
higher
patient
cholestasi
comparison
mgl
healthi
subject
correl
significantli
p
elev
ggt
level
primari
biliari
cirrhosi
bgpi
serum
level
correl
significantli
alp
p
addit
solubl
strongli
increas
serum
urin
rat
liver
diseas
interestingli
cea
predominantli
present
serum
patient
cholangioma
cholangiocarcinoma
compar
patient
cholelithiasi
patient
undergon
noncur
surgeri
wherea
detect
biliari
specimen
without
discrimin
presenc
absenc
malign
diseas
howev
put
differenti
indic
diagnosi
predict
cea
express
serum
patient
spectrum
hepatobiliari
diseas
pursu
owe
larg
lack
specif
monoclon
antibodi
could
reliabl
distinguish
cea
nca
biliari
glycoprotein
bgpi
fact
first
monoclon
antibodi
could
exclus
detect
develop
wagen
group
bgpi
human
bile
clone
cdna
reveal
homolog
nucleotid
level
correspond
domain
cea
former
nca
exhibit
approxim
homolog
cea
famili
member
domain
order
identifi
sourc
cell
produc
bgpi
human
liver
immunofluoresc
studi
undertaken
local
bgpi
bile
canaliculi
lumen
larger
bile
duct
surfac
gall
bladder
mucosa
express
pattern
human
also
confirm
rodent
promin
express
rat
hepatocellular
membran
role
promot
cellular
aggreg
hepatocyt
prompt
initi
demonstr
function
intercellular
adhes
molecul
henc
candid
cell
adhes
molecul
name
base
appar
molecular
mass
reflect
calciumdepend
homophil
hepatocellular
liposom
aggreg
format
studi
fetal
regener
rat
liver
reveal
first
express
fetal
liver
day
gestat
rat
mice
detect
earli
day
gestat
develop
gut
continu
increas
week
birth
point
adult
level
hepat
express
reach
note
express
major
isoform
increas
proport
birth
indic
involv
hepatocyt
differenti
hallmark
molecul
induc
epitheli
differenti
hypothesi
corrobor
descript
dynam
express
partial
hepatectomi
rat
figur
initi
downregul
surfac
hepatocyt
cell
prolifer
peak
restor
back
steadyst
level
day
postparti
hepatectomi
point
liver
reconstitut
ad
integrum
healthi
individu
notabl
partial
hepatectomi
healthi
individu
liver
regain
origin
mass
within
day
procedur
henc
partial
hepatectomi
model
frequent
use
analysi
wellcoordin
cellular
prolifer
differenti
tissu
regener
natur
selflimit
express
regul
hepatocyt
nuclear
factor
liverspecif
transcript
factor
human
rodent
amongst
other
coordin
express
cellular
adhes
protein
develop
mous
liver
demonstr
junction
dysform
mice
genet
delet
loss
caus
three
fourfold
downregul
transcript
express
total
abolish
express
ecadherin
embryo
adult
mice
sever
deficit
liver
homeostasi
occur
upon
loss
express
hyperprolifer
hepatocyt
disturb
lipid
homeostasi
consist
role
regul
express
sever
gene
involv
lipid
glucos
metabol
addit
character
rat
promot
reveal
bind
site
liverspecif
factor
hepatonuclear
factor
ccaatenhanc
bind
protein
cebp
hepatonuclear
factor
well
glucocorticoid
camprespons
element
bind
protein
creb
activ
protein
hepatocyt
express
two
altern
splice
isoform
differ
adhes
properti
long
isoform
mediat
direct
homophil
cellcel
adhes
short
isoform
respons
finetun
adhes
properti
lform
point
function
tissu
architectur
organ
consist
express
absent
transplant
hepatocellular
carcinoma
rat
express
regul
hepatocyt
nuclear
factor
liverspecif
transcript
factor
human
rodent
amongst
other
coordin
express
cellular
adhes
protein
develop
mous
liver
demonstr
junction
dysform
mice
genet
delet
loss
caus
three
fourfold
downregul
transcript
express
total
abolish
express
ecadherin
embryo
adult
mice
sever
deficit
liver
homeostasi
occur
upon
loss
express
hyperprolifer
hepatocyt
disturb
lipid
homeostasi
consist
role
regul
express
sever
gene
involv
lipid
glucos
metabol
addit
character
rat
promot
reveal
bind
site
liverspecif
factor
hepatonuclear
factor
ccaatenhanc
bind
protein
cebp
hepatonuclear
factor
well
glucocorticoid
camprespons
element
bind
protein
creb
activ
protein
hepatocyt
express
two
altern
splice
isoform
differ
adhes
properti
long
isoform
mediat
direct
homophil
cellcel
adhes
short
isoform
respons
finetun
adhes
properti
lform
point
function
tissu
architectur
organ
consist
express
absent
transplant
hepatocellular
carcinoma
rat
prompt
hypothesi
coordin
cell
growth
mainten
epitheli
polar
differenti
depend
express
addit
local
cellcel
contact
epitheli
cell
requir
long
cytoplasm
tail
wherea
target
apic
surfac
depend
short
cytoplasm
tail
therefor
consid
tumor
suppressor
regul
epitheli
cell
polar
signific
alter
express
featur
malign
furthermor
describ
transformationsensit
protein
loss
indic
cellular
transform
dedifferenti
hepatocyt
gener
dysregul
express
frequent
observ
malign
progress
invas
variou
carcinoma
howev
although
tumorsuppress
ascrib
varieti
tumor
mammari
prostat
colon
adenocarcinoma
increas
invas
also
assign
elev
express
other
includ
pancreat
lung
nsclc
thyroid
adenocarcinoma
melanoma
tumor
express
associ
poor
prognosi
invas
colon
focal
loss
found
earli
tumorigenesi
appear
upregul
invas
metastasi
advanc
diseas
refer
therein
gener
propos
inhibit
malign
growth
depend
long
cytoplasm
domain
growth
control
requir
phosphoryl
tyrosin
residu
within
itim
motif
tyrosin
residu
interact
inhibitori
phosphatas
blunt
growthpromot
signal
instruct
growth
factor
receptor
tyrosin
kinas
signal
downstream
srckinas
activ
human
mammari
gland
format
short
long
isoform
associ
lumen
format
express
human
mammari
carcinoma
cell
reintroduc
normal
mammari
gland
differenti
abolish
malign
phenotyp
henc
isoform
exert
diverg
role
tumorigenesi
malign
regard
human
hepatocellular
carcinoma
hcc
express
predominantli
maintain
carcinoma
welldifferenti
type
bile
canaliculi
apic
domain
pseudogland
express
contrast
poorer
differenti
tumor
area
express
membran
weaker
subsequ
confirm
later
studi
show
downregul
membran
express
andor
predomin
intracytoplasm
local
hcc
correl
higher
histolog
grade
consist
loss
express
frequent
observ
tumor
hcc
specimen
edmondsonsteinergrad
iii
iv
compar
edmondsonstein
grade
ii
congruent
loss
express
significantli
associ
tumor
size
multipl
tumor
nodul
format
satellit
nodul
capsular
vascular
invas
portal
vein
advers
patient
surviv
howev
studi
investig
isoformspecif
impact
express
subcellular
local
malign
prognosi
hcc
recent
year
becom
evid
loss
apic
membran
express
concomit
shift
intracytoplasm
local
correspond
decreas
relapsefre
surviv
hcc
liver
transplant
specimen
loss
membran
versu
promin
bile
canalicular
stain
exhibit
invers
correl
express
increas
microvascular
densiti
correl
unfavor
high
histolog
grade
regard
whether
isoform
impact
differenti
prognosi
hcc
found
predomin
express
constitut
risk
factor
hcc
recurr
predomin
express
inhibit
recurr
hcc
thu
independ
prognost
factor
diseas
recurr
qualit
compar
prognosi
estim
deriv
assess
tumor
size
cm
presenc
multinodular
hcc
vitro
shown
smad
small
mother
decapentapleg
adaptor
protein
bind
long
cytoplasm
domain
promot
nuclear
transloc
activ
transform
growth
factor
mediat
signal
may
indic
support
epitheli
mesenchym
transit
similar
hcc
express
found
invas
front
melanoma
show
signific
predict
metastat
diseas
associ
integrin
promot
cellular
invas
invasionassoci
function
depend
presenc
intact
long
cytoplasm
domain
known
identifi
substrat
insulin
receptor
ir
tyrosin
kinas
liver
insulinsensit
tissu
like
skelet
muscl
adipos
tissu
recombin
found
phosphoryl
ir
tyrosin
kinas
stabli
transfect
cell
cellfre
system
hepatocellular
membran
fraction
incub
solubil
insulin
receptor
well
hepatoma
cell
contrari
insulin
receptor
substrat
phosphoryl
insulinlik
growth
factor
receptor
igfir
upon
insulinlik
growth
factor
bind
consist
fact
downregul
mitogen
activ
insulin
downregulatori
function
phosphoryl
cell
prolifer
respons
insulin
mediat
bind
sequest
adapt
protein
shc
event
reduc
coupl
growth
factor
receptorbound
protein
rat
sarcoma
ra
gtpasesmapk
pathway
receptor
sitedirect
mutagenesi
indic
phosphoryl
conserv
tyr
rat
sequenc
requir
intact
serin
residu
cytosol
tail
moreov
phosphoryl
regul
cterminu
domain
insulin
receptor
subunit
conserv
phosphoryl
also
regul
phosphatas
bind
phosphoryl
bind
sequest
reduc
bind
insulin
receptor
lead
sustain
phosphoryl
prolong
insulin
signal
along
pathway
interact
insulin
receptor
summar
figur
activ
transform
growth
factor
mediat
signal
may
indic
support
epitheli
mesenchym
transit
similar
hcc
express
found
invas
front
melanoma
show
signific
predict
metastat
diseas
associ
integrin
promot
cellular
invas
invasionassoci
function
depend
presenc
intact
long
cytoplasm
domain
known
identifi
substrat
insulin
receptor
ir
tyrosin
kinas
liver
insulinsensit
tissu
like
skelet
muscl
adipos
tissu
recombin
found
phosphoryl
ir
tyrosin
kinas
stabli
transfect
cell
cellfre
system
hepatocellular
membran
fraction
incub
solubil
insulin
receptor
well
hepatoma
cell
contrari
insulin
receptor
substrat
phosphoryl
insulinlik
growth
factor
receptor
igfir
upon
insulinlik
growth
factor
bind
consist
fact
downregul
mitogen
activ
insulin
downregulatori
function
phosphoryl
cell
prolifer
respons
insulin
mediat
bind
sequest
adapt
protein
shc
event
reduc
coupl
growth
factor
receptorbound
protein
rat
sarcoma
ra
gtpasesmapk
pathway
receptor
sitedirect
mutagenesi
indic
phosphoryl
conserv
tyr
rat
sequenc
requir
intact
serin
residu
cytosol
tail
moreov
phosphoryl
regul
cterminu
domain
insulin
receptor
subunit
conserv
phosphoryl
also
regul
phosphatas
bind
phosphoryl
bind
sequest
reduc
bind
insulin
receptor
lead
sustain
phosphoryl
prolong
insulin
signal
along
pathway
interact
insulin
receptor
summar
figur
requir
intact
residu
mediat
indirect
associ
ir
increas
rate
endocytosi
insulininsulin
receptor
complex
clathrin
pitsvesicl
hepatocyt
facilit
subsequ
insulin
degrad
clearanc
phosphoryl
bind
sequest
phosphatas
subsequ
mediat
sustain
phosphoryl
pathway
transduc
metabol
effect
insulin
inhibit
gluconeogenesi
via
phosphoryl
nuclear
exclus
forkhead
box
protein
among
other
physiolog
correl
express
underlin
neg
effect
activ
express
furthermor
ir
intern
via
clathrinco
pit
enhanc
exposur
insulin
receptor
tyrosin
kinas
endogen
substrat
support
sustain
signal
insulin
degrad
remov
singlehead
black
arrow
indic
chain
phosphorylationdephosphoryl
event
indic
insulin
receptor
tyrosin
kinas
ir
serthr
kinas
phosphatas
doublehead
black
arrow
denot
physic
indirect
interact
ir
stabil
insulinreceptor
endocytosi
complex
increas
uptak
endocytot
vesicl
kinas
activ
ir
mandatori
receptormedi
insulin
endocytosi
via
clathrin
coat
pitsvesicl
follow
degrad
constitut
molecular
basi
insulin
clearanc
occur
primarili
liver
lower
extent
kidney
thu
tyrosin
phosphoryl
downstream
target
insulin
constitut
critic
compon
insulin
signal
pathway
regul
insulin
clearanc
hepat
insulin
remov
clear
insulin
releas
pancreat
cell
portal
circul
regul
overal
blood
level
insulin
subsequ
action
insulin
signal
liver
requir
mediat
system
insulin
sensit
demonstr
mice
condit
null
mutat
ir
liver
lirko
mice
show
loss
insulin
signal
hepatocyt
lead
sever
primari
hepat
insulin
resist
glucos
intoler
chronic
hyperinsulinemia
part
caus
impair
insulin
clearanc
interestingli
share
homolog
amino
acid
sequenc
adaptin
anchor
protein
clathrinco
pit
consist
found
associ
low
domin
highaffin
isoform
insulin
receptor
promot
receptormedi
insulin
endocytosi
degrad
hepatocyt
studi
mechan
insulin
action
amongst
first
report
describ
isoformspecif
function
altern
splice
variant
protein
state
critic
basal
phosphoryl
serinethreonin
kinas
substitut
alanin
suffici
compromis
insulinstimul
phosphoryl
respons
insulin
dominantneg
manner
mice
transgen
liverspecif
overexpress
phosphorylationdefici
dominantneg
mutant
control
apolipoprotein
promot
develop
impair
insulin
clearanc
caus
chronic
hyperinsulinemia
secondari
system
insulin
resist
glucos
intoler
hepat
steatosi
contrast
mice
global
delet
exhibit
enhanc
insulin
clearanc
result
hyperphosphoryl
constitut
activ
term
promot
insulin
intern
collect
studi
highlight
key
role
regul
insulin
sensit
promot
insulin
clearanc
nonalcohol
fatti
liver
diseas
nafld
progress
form
nonalcohol
steatohepat
nash
associ
insulin
resist
metabol
syndrom
approxim
patient
diabet
mellitu
type
commonli
develop
nafld
moreov
nafld
patient
manifest
high
preval
insulin
resist
approxim
nafld
patient
obes
although
nafld
may
also
occur
lean
patient
hepat
steatosi
nafld
associ
elev
de
novo
lipogenesi
reduc
vldltriglycerid
output
surplu
free
fatti
acid
ffa
associ
peripher
insulin
resist
releas
inflammatori
chemokin
eicosanoid
mitochondri
dysfunct
therefor
consid
hepat
manifest
metabol
syndrom
howev
owe
pauciti
anim
model
mimick
human
nafld
relationship
insulin
resist
nafld
remain
challeng
henandegg
question
root
observ
nafld
emerg
multipl
parallel
hit
involv
inflamm
lipotox
insulin
resist
gut
leaki
dysbiosi
inflammatori
process
initi
nafldassoci
inflamm
progress
nash
resid
liver
well
extrahepat
tissu
white
adipos
tissu
wat
gut
see
previou
section
nafld
may
progress
nash
chronic
irrevers
inflammatori
complic
nafld
henc
import
identifi
inflammatori
trigger
mediat
inflamm
nafld
pave
way
nash
progress
subsequ
chronic
hepat
nash
induc
progress
liver
fibrosi
cirrhosi
predispos
hepatocellular
carcinoma
nash
character
macrovesicular
steatosi
inflammatori
infiltr
hepatocyt
balloon
variabl
degre
characterist
chickenwir
fibrosi
nash
becom
overal
second
lead
caus
liver
transplant
usa
white
femal
nash
late
outnumb
alcohol
liver
diseas
chronic
hepat
c
infect
lead
caus
transplant
current
world
popul
estim
exhibit
nafld
howev
incid
nash
vari
among
differ
ethnic
also
modul
genet
variat
lifestyl
diet
composit
gut
microbiom
among
environment
factor
physiolog
portal
insulin
level
exce
peripher
circul
threefold
consist
higher
transcript
level
lipogen
gene
fatti
acid
synthasefasn
hepatocyt
due
activ
sterol
respons
element
bind
protein
transcript
factor
despit
higher
level
lipogen
gene
liver
activ
fasn
tissu
almost
undetect
normal
insulinem
condit
minim
de
novo
lipogenesi
protect
mechan
mediat
pulsatil
insulin
releas
pancreat
cell
acut
activ
insulin
signal
pathway
phosphoryl
hepatocyt
turn
facilit
endocytosi
insulin
target
degrad
pathway
concurr
lead
bind
fasn
suppress
activ
manner
promot
appropri
insulin
clearanc
mediat
insulin
sensit
restrict
de
novo
lipogenesi
liver
normal
insulinem
condit
chronic
hyperinsulinemia
insulin
clearanc
impair
pulsatil
insulin
secret
diminish
result
blunt
acut
insulin
signal
hepat
insulin
resist
limit
counterregul
lipogenesi
togeth
enhanc
hepat
lipid
product
favor
reesterif
fatti
acid
caus
hepat
steatosi
addit
lipid
redistribut
viscer
adipos
depot
store
eventu
lipolysi
occur
drive
flow
toxic
ffa
viscer
fat
liver
tissu
substanti
ectop
fat
accumul
caus
system
insulin
addit
ffa
releas
adiposetissueinfiltr
bonemarrowderiv
cell
differenti
proinflammatori
macrophag
releas
adipokin
chemokin
contribut
system
insulin
resist
exemplifi
suppress
effect
insulin
signal
addit
adipokin
disturb
gut
permeabl
barrier
enhanc
penetr
pathogenassoci
molecular
pattern
pamp
microbeassoci
molecular
pattern
mamp
circul
preprogram
liverresid
immun
cell
kupffer
cell
cell
undergo
inflamm
facilit
loss
toler
steatohepat
nash
involv
cytokin
respons
drive
liver
injuri
elev
level
proinflammatori
cytokin
like
interferon
first
apoptosi
signal
fa
ligand
detect
serum
liver
adipos
tissu
human
mice
nash
phenotyp
rel
level
correl
diseas
sever
especi
elev
bolster
reduc
steatohepat
apopotosi
fibrosi
antibodi
infliximab
tm
obes
insulinresist
human
nafld
exhibit
reduc
level
hepat
linear
relationship
sever
diseas
similarli
primari
hepatocyt
obes
human
rat
model
obes
hepat
steatosi
exhibit
declin
level
experi
mous
model
target
express
global
liver
shed
light
hepat
exhibit
uniqu
regulatori
properti
connect
insulin
clearanc
lipid
metabol
pathogenesi
nafldnash
global
null
delet
gene
liverspecif
inactiv
impair
insulin
extract
caus
hyperinsulinemia
follow
insulin
resist
secondari
increas
hepat
lipid
product
redistribut
white
adipos
tissu
yield
viscer
adipos
lipolysi
figur
liverspecif
inactiv
impair
insulin
extract
caus
hyperinsulinemia
follow
insulin
resist
secondari
increas
hepat
lipid
product
redistribut
white
adipos
tissu
yield
viscer
adipos
lipolysi
figur
hepat
inactiv
global
loss
function
express
impair
insulin
clearanc
caus
insulin
resist
fatti
liver
diseas
addit
disturb
energi
homeostasi
initi
mutat
impair
insulin
clearanc
promot
hyperinsulinemia
insulin
resist
hyperinsulinemia
turn
promot
lipogenesi
liver
accompani
elev
fatti
acid
synthas
fasn
express
activ
follow
hepat
fat
accumul
subsequ
nafld
nash
emerg
accompani
elev
inflammatori
cytokin
product
emerg
macrosteatosi
well
fibrosi
acceler
highfatdiet
feed
mutant
mice
chronic
liver
inflamm
ultim
lead
progress
liver
fibrosi
cirrhosi
parallel
insulin
resist
hyperinsulinemia
fatti
liver
diseas
disturb
energi
homeostasi
viscer
adipos
system
inflamm
emerg
addit
leptin
resist
elev
hypothalam
fasn
express
hyperphagia
reduct
energi
expenditur
fuel
viciou
cycl
ultim
contribut
cardiometabol
abnorm
mice
upward
downward
red
arrow
indic
increas
decreas
respect
cardiometabol
inflammatori
eventsparamet
singlehead
black
arrow
indic
hierarch
chain
event
emerg
metabol
dysfunct
doublehead
black
arrow
depict
feedback
loop
point
toward
connect
viscer
obes
adipos
tissu
inflamm
one
hand
hepatosteat
central
control
circuit
obes
hyperinsulinemia
corrupt
repress
hepat
fatti
acid
synthas
fasn
activ
hyperinsulinemia
support
hepat
steatosi
lipogenesi
accompani
reduct
hepat
furthermor
global
null
mice
develop
leptin
resist
contribut
hyperphagia
fat
accumul
reduct
physic
inact
lead
obes
moreov
hyperinsulinemia
mice
induc
hypothalam
fasn
level
activ
contribut
hyperphagia
physic
inact
furthermor
fatti
acid
inhibit
muscl
mice
enhanc
triglycerid
accumul
convers
exclus
transgen
hepat
restor
function
revers
metabol
abnorm
caus
global
delet
mice
exclus
transgen
liverspecif
restor
includ
hyperinsulinemia
insulin
resist
steatohepat
moreov
fasn
activ
hypothalamu
repress
contribut
significantli
normal
hyperphagia
hepat
inactiv
global
loss
function
express
impair
insulin
clearanc
caus
insulin
resist
fatti
liver
diseas
addit
disturb
energi
homeostasi
initi
mutat
impair
insulin
clearanc
promot
hyperinsulinemia
insulin
resist
hyperinsulinemia
turn
promot
lipogenesi
liver
accompani
elev
fatti
acid
synthas
fasn
express
activ
follow
hepat
fat
accumul
subsequ
nafld
nash
emerg
accompani
elev
inflammatori
cytokin
product
emerg
macrosteatosi
well
fibrosi
acceler
highfatdiet
feed
mutant
mice
chronic
liver
inflamm
ultim
lead
progress
liver
fibrosi
cirrhosi
parallel
insulin
resist
hyperinsulinemia
fatti
liver
diseas
disturb
energi
homeostasi
viscer
adipos
system
inflamm
emerg
addit
leptin
resist
elev
hypothalam
fasn
express
hyperphagia
reduct
energi
expenditur
fuel
viciou
cycl
ultim
contribut
cardiometabol
abnorm
mice
upward
downward
red
arrow
indic
increas
decreas
respect
cardiometabol
inflammatori
eventsparamet
singlehead
black
arrow
indic
hierarch
chain
event
emerg
metabol
dysfunct
doublehead
black
arrow
depict
feedback
loop
point
toward
connect
viscer
obes
adipos
tissu
inflamm
one
hand
hepatosteat
central
control
circuit
obes
hyperinsulinemia
corrupt
repress
hepat
fatti
acid
synthas
fasn
activ
hyperinsulinemia
support
hepat
steatosi
lipogenesi
accompani
reduct
hepat
furthermor
global
null
mice
develop
leptin
resist
contribut
hyperphagia
fat
accumul
reduct
physic
inact
lead
obes
moreov
hyperinsulinemia
mice
induc
hypothalam
fasn
level
activ
contribut
hyperphagia
physic
inact
furthermor
fatti
acid
inhibit
muscl
mice
enhanc
triglycerid
accumul
convers
exclus
transgen
hepat
restor
function
revers
metabol
abnorm
caus
global
delet
mice
exclus
transgen
liverspecif
restor
includ
hyperinsulinemia
insulin
resist
steatohepat
moreov
fasn
activ
hypothalamu
repress
contribut
significantli
normal
hyperphagia
obes
hepat
steatohepat
associ
impair
insulin
clearanc
demonstr
repress
hepat
express
highfat
hf
intak
via
peroxisomeproliferatoractiv
receptor
depend
mechan
forc
liverspecif
transgen
overexpress
protect
liver
white
adipos
tissu
dietinduc
metabol
inflammatori
fibrogen
respons
adenoviralmedi
reintroduct
intact
wildtyp
hepatocyt
protect
advers
neg
metabol
effect
highfat
hf
diet
includ
hyperinsulinemia
hepat
lipid
product
steatohepat
similarli
treatment
hffed
wildtyp
mice
exenatid
longact
glucagonlik
receptor
agonist
stimul
insulin
secret
prevent
dietinduc
insulin
resist
alter
metabol
restor
hepat
express
via
pathway
exenatid
treatment
also
protect
dietinduc
steatohepat
activ
profibrogen
signal
pathway
collect
studi
emphas
import
regul
insulin
sensit
homeostat
insulin
level
turn
regul
insulin
secret
pancreat
cell
well
hepat
extract
addit
insulin
resist
hepatosteatosi
mice
develop
endotheli
dysfunct
well
cardiac
hypertrophi
septal
wall
thicken
reduct
cardiac
perform
disturb
vasomotor
activ
elev
cardiac
aortic
lipid
content
increas
oxid
stress
apoptosi
endotheli
dysfunct
caus
insulin
resist
dyslipidemia
hyperglycemia
mice
caus
reduct
endotheli
nitric
oxid
level
due
impair
endotheli
activ
endotheli
nitric
oxid
synthas
pathway
addit
imbalanc
receptor
ab
express
furthermor
insulin
signal
heart
tissu
compromis
owe
hyperinsulinemiadriven
reduc
insulin
receptor
number
liverspecif
rescu
howev
revers
abnorm
mice
normal
plasma
level
prevent
leukocyt
adhes
aortic
wall
data
indic
hepat
express
necessari
suffici
maintain
insulin
metabol
homeostasi
protect
insulin
resist
consequ
well
cardiovascular
diseas
elicit
metabol
inflamm
express
b
nk
dentrit
cell
granulocyt
monocyt
macrophag
lymphocyt
express
low
level
undergo
rapid
upregul
upon
cellular
activ
contrast
granulocyt
differenti
antigen
control
granulopoiesi
delay
neutrophil
apoptosi
gener
associ
protect
hyperinflamm
result
either
inappropri
expans
cellular
precursor
dysregul
granulopoeiesi
neutrophilia
mice
associ
enhanc
product
respons
stimul
tolllik
receptor
exagger
effector
cell
respons
dysfunct
b
cell
activ
surviv
regul
immun
cell
ligand
bind
properti
either
monom
homoor
heterodim
play
pivot
role
addit
homophil
interact
bind
member
cea
famili
human
heterophil
fashion
also
serv
receptor
vast
varieti
pathogen
human
mice
human
n
gonorrho
n
meningitidi
h
influenza
catharali
h
pylori
ecoli
salmonella
spp
candida
albican
hepat
viru
mhv
mice
horst
ak
wagen
c
unpublish
observ
pathogen
bind
homomer
heteromer
interact
ceacam
occur
predominantli
via
ntermin
domain
mice
express
rel
express
densiti
ci
homoand
heterodim
isom
either
long
short
cytoplasm
domain
determin
signal
outcom
provid
molecular
basi
complex
signal
integr
effect
cellular
activ
prolifer
cytokin
product
control
sever
factor
includ
overal
express
level
subcellular
local
ii
spatiotempor
upregul
express
isoform
express
cognat
immun
cell
tissu
iii
rel
ratio
major
isoform
l
vs
iv
selflig
heterolig
ci
tran
either
molecul
coreceptor
neighbor
cell
furthermor
bind
pathogenderiv
heteroligand
disrupt
homodimer
interact
therebi
modul
downstream
signal
sinc
homeostasi
cell
compart
play
pivot
role
etiolog
autoimmun
liver
diseas
immunemedi
liver
injuri
focu
section
set
control
cell
activ
induct
regulatori
cell
implic
hepat
mucos
immun
gastrointestin
tract
member
cea
famili
express
activ
cell
rapidli
upregul
upon
tcr
stimul
naiv
cell
express
low
level
store
intracellularli
endosom
compart
activ
cell
show
overlap
express
kinet
activ
marker
preced
express
cytotox
tlymphocyteassoci
protein
indic
inhibitori
form
interfer
cell
activ
prior
therefor
independ
immun
checkpoint
regul
exert
opposit
role
control
cell
activ
act
independ
cell
activ
cell
receptor
tcr
stimul
trigger
cytokin
product
respons
well
upregul
depend
nuclear
factor
activ
transcript
nfat
mediat
signal
nfat
signal
propag
express
contrast
control
cell
activ
inhibit
downstream
signal
pathway
mention
contain
itimitsm
motif
phosphoryl
srclike
kinas
like
lck
cell
mediat
bind
blunt
downstream
kinasedepend
pathway
includ
activ
chain
tcrassoci
protein
kinas
mitogen
proinflammatori
kinas
extracellular
signalregul
kinas
erk
junactiv
kinas
jnk
recent
report
demonstr
recruit
lck
tcrsignal
complex
cell
depend
express
bind
filamin
stabil
immunolog
synaps
support
cell
prolifer
prevent
exhaust
viral
infect
addit
interfer
viral
replic
human
cytomegali
viru
infect
via
downregul
molecular
target
rapamycin
mtor
activ
furthermor
associ
chain
receptor
modul
bind
normal
requir
cellmedi
cytolyt
function
elicit
tcr
activ
blockag
homophil
bind
suppress
cytolyt
function
elicit
tcrsignal
addit
interact
regul
fasinduc
apoptosi
jurkat
cell
cell
activ
also
larg
depend
kinet
isoform
express
cell
substanti
evid
exist
support
notion
act
inhibitori
receptor
cell
activ
wherea
isoform
independ
cell
activ
mucos
inflamm
model
inflammatori
bowel
diseas
provok
dextran
sodium
sulfat
dss
trinitrobenzin
sulfon
acid
oxazolon
paint
heterophil
ligat
antibodi
homophil
ligat
solubl
recombin
fusion
protein
inhibit
mix
lymphocyt
reaction
vitro
haptenmedi
coliti
vivo
associ
inhibit
product
proinflammatori
cytokin
via
tbet
signal
cell
differenti
signal
henc
mice
exhibit
higher
product
proinflammatori
cytokin
due
lack
express
interestingli
ligat
mhv
spike
protein
block
differenti
toward
type
addit
also
convey
toler
interact
immun
checkpoint
regul
cell
immunoglobulin
domain
mucin
protein
activationinduc
inhibitori
coreceptor
coexpress
toler
induct
chronic
viral
infect
inflammatori
bowel
diseas
ibd
colon
tumor
associ
via
extracellular
domain
heterodim
ci
tran
interact
requir
enhanc
cell
surfac
express
matur
well
promot
inhibitori
function
manner
express
cell
convey
toler
interact
anoth
immun
coreceptor
howev
describ
also
adopt
tolerogen
properti
propag
regulatori
cell
induct
stabil
depend
contextu
express
variant
short
cytoplasm
isoform
inde
besid
gener
accept
inhibitori
function
isoform
express
control
cellborn
inflamm
via
elicit
regulatori
cell
addit
extracellular
interact
induct
toler
via
mediat
immuneinhibitori
signal
mucos
immun
affect
specif
isoform
express
gut
describ
anoth
dimens
complex
regulatori
network
finetun
immun
regul
via
ad
observ
tissuespecif
predomin
isoform
express
intestin
gutassoci
lymphoid
tissu
predomin
cellassoci
isoform
found
human
mice
compar
contrast
major
isoform
express
cell
extraintestin
tissu
import
note
sinc
cell
activ
import
elicit
cell
subset
educ
latenc
peptid
lap
cell
induc
mucos
immunityenhanc
follicular
helper
tfh
cell
trigger
product
secret
iga
follicular
b
cell
mice
secretori
mucos
immun
elicit
upon
gastrointestin
bacteri
antigen
exposur
demonstr
challeng
wildtyp
transgen
mice
overexpress
cell
l
monocytogen
lap
express
treg
popul
mesenter
lymph
node
especi
interest
sinc
appear
exhibit
uniqu
immun
suppress
capac
mediat
note
cell
induc
oral
feed
antibodi
suppress
experiment
autoimmun
enceph
eae
intraven
inject
antibodi
produc
effect
induc
apoptosi
cell
activ
thu
lead
cell
delet
model
l
monocytogen
infect
mice
fail
substanti
expand
lap
popul
upon
oral
feed
antibodi
exhibit
alter
treg
pool
gastrointestinalassoci
lymphat
tissu
addit
mice
express
overexpress
cell
compart
exhibit
increas
divers
gut
microbiota
compar
control
predomin
isoform
requir
persist
exposur
mucos
antigen
requir
confer
robust
toward
pathogen
enteropathogen
l
monocytogen
hypersensit
toward
l
monocytogen
also
report
mice
result
dysregul
granulopoiesi
absenc
myeloid
compart
addit
neutrophilia
result
impair
inhibit
activ
downstream
gcsf
receptor
control
granulopoiesi
turn
lead
septicemia
l
monocytogen
infect
dramat
elev
addit
act
promin
receptor
commens
pathogen
gastrointestin
microb
see
modul
gutassoci
immun
system
toler
releas
bacteri
metabolit
instrument
mediat
liver
toler
via
induct
cell
popul
migrat
intestin
suppress
inflamm
hepat
immunolog
environ
gutliv
axi
aberr
gut
permeabl
import
determin
emerg
metabol
dysfunct
caus
accompani
liver
inflamm
metabol
syndrom
obes
nafldnash
see
addit
mucos
immun
recent
demonstr
treg
induct
stabil
liver
also
control
express
murin
cell
connect
gut
liver
contribut
significantli
extraintestin
manifest
ibd
vice
versa
either
atyp
immun
cell
home
mucos
cell
persist
reloc
selfreact
cell
liver
howev
immunemedi
liver
inflamm
ibd
occur
independ
often
appear
disconnect
rel
time
cours
circul
mucos
cell
via
thorac
duct
enabl
immunolog
crosstalk
gut
liver
oral
toler
compromis
introduct
portacav
shunt
yet
unknown
whether
mucos
cell
could
travel
liver
import
tolerogen
inflammatori
signal
primari
biliari
cirrhosi
pbc
primari
scleros
cholang
psc
autoimmun
hepat
aih
autoimmun
diseas
share
common
hallmark
compromis
treg
homeostasi
often
hyperexpans
enhanc
proinflammatori
activ
effector
cell
also
observ
type
diabet
rheumatoid
arthriti
graftversu
hostdiseas
treg
instrument
upkeep
peripher
toler
mediat
immunosuppress
exert
immun
suppress
granzym
aor
bdepend
kill
target
effector
cell
competit
microenvironment
pool
inhibit
dendrit
matur
function
celltocel
contact
requir
treg
exert
suppress
function
vitro
control
induct
expans
regulatori
cell
effector
cell
via
bind
high
low
affin
receptor
treg
high
affin
receptor
chain
trimer
high
affin
receptor
express
high
level
ensur
effici
bind
even
cytokin
present
microenviron
low
amount
larg
produc
effector
cell
prefer
consumpt
treg
ensur
expans
treg
function
surviv
depend
phosphoryl
signal
transduc
activ
transcript
nuclear
transloc
subsequ
express
date
shown
therapi
low
dose
effect
autoimmun
diseas
lupu
erythematod
type
diabet
rheumatoid
arthriti
graftversu
host
diseas
partial
induc
endogen
expans
treg
human
patient
import
approach
emphas
observ
polymorph
human
result
reduct
treg
suppress
function
patient
primari
scleros
cholang
novel
antibodi
develop
allow
select
target
expans
treg
preferenti
induc
phosphoryl
discuss
regul
tcrand
signal
howev
evid
short
isoform
similarli
respond
signal
specif
impact
cell
polar
describ
mous
model
immunemedi
hepat
reflect
sever
aspect
cell
activ
includ
cytokin
respons
observ
autoimmun
hepat
concanavalin
cona
hepat
demonstr
induct
intrahepat
regulatori
cell
depend
product
cell
product
significantli
reduc
cell
cona
bind
liver
sinusoid
endothelium
activ
liver
resid
immun
cell
trigger
cascad
inflamm
initi
product
effector
cell
monocytesmacrophag
respect
subsequ
hepatocyt
undergo
traildepend
cell
death
therebi
enhanc
hepat
releas
damageassoci
molecular
pattern
damp
alarmin
exacerb
liver
injuri
inflamm
activ
innat
lymphoid
myeloid
cell
mice
show
sever
extend
cours
cona
hepat
significantli
elev
liver
enzym
hepat
necroinflamm
furthermor
analysi
intrahepat
cell
popul
show
reduct
intrahepat
treg
concurr
hyperexpans
cell
phenotyp
also
transmitt
transfer
cell
immunecompromis
host
strain
extend
analys
address
isoform
express
cell
cona
challeng
found
upregul
cell
crucial
dampen
cellborn
hyperinflamm
contrast
cell
observ
upregul
henc
initi
product
effector
cell
essenti
induc
appropri
treg
cell
liver
sinc
express
enhanc
signal
via
receptor
induc
phosphoryl
treg
master
regul
transcript
factor
activ
requir
nuclear
transloc
bind
promot
receptor
treg
surviv
factor
therefor
foster
induct
stabil
treg
cell
phosphoryl
impair
addit
interact
common
cytokin
receptor
chain
highaffin
chain
date
howev
unknown
whether
associ
stabil
express
cell
surfac
modul
affin
receptor
steric
interact
addit
treg
could
compet
local
pool
subsequ
induc
apoptosi
neighbor
effector
cell
depriv
respect
import
note
cell
jurkat
cell
undergo
first
apoptosi
signal
fa
depend
apoptosi
activ
induct
apoptosi
depend
interact
long
cytoplasm
domain
ablat
mutagenesi
critic
residu
within
armadillo
repeat
henc
activationinduc
apoptosi
may
impair
cell
anoth
neg
regul
feedback
loop
miss
cell
compris
induct
express
taken
togeth
data
describ
dual
role
two
major
isoform
cell
activ
polar
although
net
outcom
cell
regul
dampen
inflamm
initi
inflammatori
cascad
trigger
tcrdepend
upregul
stimulatori
isoform
activ
cell
requir
induc
tcrdepend
nuclear
factor
activ
cell
nfat
activ
product
subsequ
signal
pathway
confer
express
treg
induct
hand
hyperactiv
effector
cell
prevent
upregul
popul
treg
popul
studi
demonstr
isoform
express
control
cell
homeostasi
mainten
toler
spatiotempor
regul
isoform
express
liver
depict
figur
b
howev
whether
could
assist
conform
stabil
bind
receptor
whether
solubl
ceacam
antibodi
could
potenti
support
treg
expans
enhanc
suppress
function
autoimmun
liver
diseas
remain
demonstr
subsequ
nfat
nuclear
transloc
transcript
initi
act
independ
signal
unit
cell
two
itim
motif
phosphoryl
src
famili
kinas
subsequ
bind
dephosphoryl
consequ
block
tcrmediat
activ
mapk
signal
cell
molecular
adaptor
relay
signal
via
defin
yet
initi
product
key
event
treg
induct
stabil
b
upon
tcrinduc
product
signal
complex
induc
phosphoryl
phosphoryl
transloc
nucleu
act
transcript
factor
heterodimer
heterotetramer
complex
control
transcript
key
function
treg
gene
indic
curv
black
arrow
subsequ
nfat
nuclear
transloc
transcript
initi
act
independ
signal
unit
cell
two
itim
motif
phosphoryl
src
famili
kinas
subsequ
bind
dephosphoryl
consequ
block
tcrmediat
activ
mapk
signal
cell
molecular
adaptor
relay
signal
via
defin
yet
initi
product
key
event
treg
induct
stabil
b
tcrinduc
product
signal
complex
induc
phosphoryl
phosphoryl
transloc
nucleu
act
transcript
factor
heterodimer
heterotetramer
complex
control
transcript
key
function
treg
gene
indic
curv
black
arrow
refer
therein
singlehead
black
arrow
indic
chain
downstream
phosphoryl
dephosphoryl
event
phosphoryl
elicit
well
tcr
conjuct
turn
recruit
phosphyl
local
phosphatas
tcr
consequ
block
mapk
activ
black
bar
question
mark
downstream
indic
direct
activ
phosphoryl
nfat
via
potenti
physic
interact
remain
determin
reprint
adapt
permiss
wiley
son
adopt
dual
role
tissu
differenti
cellular
prolifer
motil
signal
finetun
celland
tissuespecif
rel
distribut
isoform
henc
support
inhibit
tissu
differenti
tumorigenesi
metastasi
moreov
selflig
ci
tran
well
heterophil
bind
ceacam
microbi
adhesin
growth
factor
receptor
tyrosin
kinas
immun
checkpoint
regul
control
effect
cellular
signal
express
gener
upregul
inflamm
exert
inhibitori
activ
signal
tempor
control
long
short
isoform
express
date
diseaseassoci
polymorph
mutat
ceacam
describ
human
indic
famili
adhes
molecul
fulfil
nonredund
function
immun
cellular
differenti
metabol
regul
howev
dysregul
ceacam
express
commonli
observ
varieti
tumor
select
isoform
express
tissuespecif
manner
contribut
gener
regulatori
cell
organ
protect
gastrointestin
tract
liver
organ
central
role
upkeep
system
toler
instanc
express
cell
essenti
elicit
protect
mucos
infect
immunemedi
liver
injuri
via
treg
induct
wherea
express
effector
cell
neutrophil
dampen
inflamm
addit
control
insulin
clearanc
protect
insulin
resist
obes
watassoci
inflamm
hepatosteatosi
nafld
nash
fibrosi
cardiovascular
diseas
bolster
observ
mice
global
delet
express
remark
rescu
hepat
express
background
suffic
restor
metabol
homeostasi
even
highfat
diet
intak
ubiquit
express
human
howev
pose
substanti
challeng
develop
therapeut
order
prevent
advers
sideeffect
requir
indepth
mechanist
futur
studi
work
support
deutsch
forschungsgemeinschaft
consorti
grant
project
akh
gt
also
nation
institut
health
usa
smn
author
declar
conflict
interest
autoimmun
hepat
alp
alkalin
phosphatas
adapt
protein
bgpi
biliari
glycoproteini
ccam
calciumdepend
cellcel
adhes
molecul
cd
cluster
differenti
carcinoembryon
antigenrel
cell
adhes
molecul
protein
human
rodent
gene
encod
protein
mice
gene
